Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roland F Staack

Showing results (11-20 of 81) with videos related to

Pageof 9
Sort By:
Current Drug Metabolism|June 25, 2005
Metabolism of designer drugs of abuseRoland F Staack, Hans H Maurer
Bioanalysis|May 10, 2019
Evaluation of potential biotin interference in immunogenicity testingAlexander Pöhler, Janine Faigle, Roland F Staack
Rapid Communications in Mass Spectrometry : RCM|February 3, 2005
The combination of liquid chromatography/tandem mass spectrometry and chip-based infusion for improved screening and characterization of drug metabolitesRoland F Staack, Emmanuel Varesio, Gérard Hopfgartner
Bioanalysis|March 8, 2012
Mathematical simulations for bioanalytical assay development: the (un-)necessity and (im-)possibility of free drug quantificationRoland F Staack, Gregor Jordan, Julia Heinrich
Journal of Mass Spectrometry : JMS|September 25, 2003
New designer drug 1-(3-trifluoromethylphenyl) piperazine (TFMPP): gas chromatography/mass spectrometry and liquid chromatography/mass spectrometry studies on its phase I and II metabolism and on its toxicological detection in rat urineRoland F Staack, Gieselher Fritschi, Hans H Maurer
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|May 3, 2003
New designer drug p-methoxymethamphetamine: studies on its metabolism and toxicological detection in urine using gas chromatography-mass spectrometryRoland F Staack, Josef Fehn, Hans H Maurer
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|May 17, 2002
Studies on the metabolism and toxicological detection of the new designer drug N-benzylpiperazine in urine using gas chromatography-mass spectrometryRoland F Staack, Giselher Fritschi, Hans H Maurer
Bioanalysis|November 28, 2013
Free analyte QC concept: a novel approach to prove correct quantification of free therapeutic protein drug/biomarker concentrationsRoland F Staack, Gregor Jordan, Uwe Dahl, et al.
Therapeutic Drug Monitoring|July 17, 2004
Studies on the human metabolism and the toxicologic detection of the cough suppressant dropropizine in urine using gas chromatography-mass spectrometryRoland F Staack, Denis S Theobald, Hans H Maurer
Bioanalysis|September 28, 2017
Evaluation of the potential use of hybrid LC-MS/MS for active drug quantification applying the 'free analyte QC concept'Gregor Jordan, Ichio Onami, Julia Heinrich, et al.
Pageof 9

Showing results (11-20 of 81) with videos related to

Sort By:
Pageof 9
Current Drug Metabolism|June 25, 2005
Metabolism of designer drugs of abuseRoland F Staack, Hans H Maurer
Bioanalysis|May 10, 2019
Evaluation of potential biotin interference in immunogenicity testingAlexander Pöhler, Janine Faigle, Roland F Staack
Rapid Communications in Mass Spectrometry : RCM|February 3, 2005
The combination of liquid chromatography/tandem mass spectrometry and chip-based infusion for improved screening and characterization of drug metabolitesRoland F Staack, Emmanuel Varesio, Gérard Hopfgartner
Bioanalysis|March 8, 2012
Mathematical simulations for bioanalytical assay development: the (un-)necessity and (im-)possibility of free drug quantificationRoland F Staack, Gregor Jordan, Julia Heinrich
Journal of Mass Spectrometry : JMS|September 25, 2003
New designer drug 1-(3-trifluoromethylphenyl) piperazine (TFMPP): gas chromatography/mass spectrometry and liquid chromatography/mass spectrometry studies on its phase I and II metabolism and on its toxicological detection in rat urineRoland F Staack, Gieselher Fritschi, Hans H Maurer
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|May 3, 2003
New designer drug p-methoxymethamphetamine: studies on its metabolism and toxicological detection in urine using gas chromatography-mass spectrometryRoland F Staack, Josef Fehn, Hans H Maurer
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|May 17, 2002
Studies on the metabolism and toxicological detection of the new designer drug N-benzylpiperazine in urine using gas chromatography-mass spectrometryRoland F Staack, Giselher Fritschi, Hans H Maurer
Bioanalysis|November 28, 2013
Free analyte QC concept: a novel approach to prove correct quantification of free therapeutic protein drug/biomarker concentrationsRoland F Staack, Gregor Jordan, Uwe Dahl, et al.
Therapeutic Drug Monitoring|July 17, 2004
Studies on the human metabolism and the toxicologic detection of the cough suppressant dropropizine in urine using gas chromatography-mass spectrometryRoland F Staack, Denis S Theobald, Hans H Maurer
Bioanalysis|September 28, 2017
Evaluation of the potential use of hybrid LC-MS/MS for active drug quantification applying the 'free analyte QC concept'Gregor Jordan, Ichio Onami, Julia Heinrich, et al.
Pageof 9